PTR [PETROCHINA CO] 6-K: (Original Filing)

[THIS DOCUMENT IS IMPORTANT AND REQUIRES YOUR IMMEDIATE ATTENTION If you are in any doubt If you have sold or transferred PetroChina Company Limited, PETROCHINA COMPANY LIMITED (a joint stock limited company incorporated in the People’s Republic of China with limited liability) (Stock Code: 857) GENERAL MANDATE TO ISSUE SHARES IMPORTANT NOTICE: PLEASE NOTE THAT THE SOLE PURPOSE OF DISTRIBUTING] [99.1 Announcement dated April 5, 2012 relating to the general mandate to issue shares and the notice of annual general meeting for the year 2011. PetroChina Company Limited Dated: April 5, 2012 Li Hualin]

By | 2016-03-28T22:35:06+00:00 April 5th, 2012|Categories: Chinese Stocks, PTR, SEC Original|Tags: , , , , , |0 Comments

HIMX [Himax Technologies] 6-K: (Original Filing)

[Himax Technologies Raises First Quarter Revenue, Gross Margin and EPS Guidance TAINAN, Taiwan, April 5, 2012 (GLOBE NEWSWIRE) -- Himax Technologies, Inc. ("Himax" or "Company") (Nasdaq:HIMX) today announced that it expects its first quarter revenues, gross margin and EPS to exceed the Company's previously announced guidance on February 13, 2012. Himax is revising its first quarter revenue guidance to $166.7] [FORM 6-K April 2012 000-51847 Himax Technologies, Inc. No.26, Zih Lian Road, Fonghua Village, Note: Note: Himax Technologies, Inc. Chief Financial Officer 6-K 1 document.htm FORM 6-K FILING DOCUMENT]

By | 2016-03-23T12:48:32+00:00 April 5th, 2012|Categories: Chinese Stocks, HIMX, SEC Original|Tags: , , , , , |0 Comments

BSPM [Biostar Pharmaceuticals,] 8-K: (Original Filing)

[ARTICLES OF AMENDMENT TO THE ARTICLES OF INCORPORATION OF BIOSTAR PHARMACEUTICALS, INC. This is to certify that: FIRST SECOND THIRD FOURTH IN WITNESS WHEREOF Biostar Pharmaceuticals, Inc. Ronghua Wang Shuang Gong Chief Executive Officer Secretary EX-3.1 2 ex3-1.htm] [BIOSTAR PHARMACEUTICALS TO EFFECT REVERSE STOCK SPLIT -- XIANYANG, China, April 3, 2012 As a result of the reverse stock split, the number of outstanding common shares will be reduced to approximately 9,398,892. Fractional stockholdings will be rounded up to the nearest whole number. The reverse stock split will affect all stockholders uniformly and will not affect any stockholder’s ownership]

By | 2016-03-03T12:06:04+00:00 April 4th, 2012|Categories: BSPM, Chinese Stocks, SEC Original|Tags: , , , , , |0 Comments

BSPM [Biostar Pharmaceuticals,] 8-K: (Original Filing)

[ARTICLES OF AMENDMENT TO THE ARTICLES OFORPORATION OF BIOSTAR PHARMACEUTICALS, This is to certify that: SECOND THIRD FOURTH IN WITNESS WHEREOF Biostar Pharmaceuticals, Ronghua Wang Shuang Gong Chief Executive Officer Secretary ex3-1.htm 2 EX-3.1] [BIOSTAR PHARMACEUTICALS TO EFFECT REVERSE STOCKLIT -- XIANYANG, China, April 3, 2012 a result of the reverse stocklit, the number of outstandingmmon shares will be reduced to approximately 9,398,892.Fractional stockholdings will be rounded up to the nearest whole number.The reverse stocklit will affectl stockholders uniformly and will not affect any stockholders ownership percentage of the]

By | 2016-02-07T15:52:17+00:00 April 4th, 2012|Categories: BSPM, Chinese Stocks, SEC Original|Tags: , , , , , |0 Comments

GSOL [GLOBAL SOURCES] 6-K: (Original Filing)

[The Company's shares trading on NASDAQ was halted on April 3, 2012 at 10:13:42 a.m. Eastern Time by NASDAQ for an “additional information request”, which was subsequently provided by the Company. The trading of the Company’s shares is scheduled to resume on Wednesday, April 4, 2012, at 7:15 a.m. Eastern Time. GLOBAL SOURCES LTD.]

By | 2016-03-07T18:00:28+00:00 April 4th, 2012|Categories: Chinese Stocks, GSOL, SEC Original|Tags: , , , , , |0 Comments

MR [Mindray Medical International] SC 13G/A: (Original Filing)

[USIP O C 13G Page 1 of 15 Joint Filing Agreement March This Agreement may be executed in multiple counterparts, each of which shall constitute an original, one and the same instrument. Commonwealth Bank of Australia John Damien Hatton Company Secretary Colonial Holding Company Limited John Damien Hatton Director Commonwealth Insurance Holdings Limited John Damien Hatton Director Colonial First State] [USIP O C 13G Page 1 of 15 Item 7 Information The securities being reported on by the reporting persons herein as parent holding companies are owned, or may be deemed to be beneficially owned as follows: Company Type of Company. First State Investments (Hong Kong) Limited IA (HK registered) First State Investments International Ltd. IA (US registered) First State]

MR [Mindray Medical International] SC 13G/A: (Original Filing)

[USIP O C 13G Page 2 of 15 1. NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OFOVE PERSONmmonwealth Bank of Australia * 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A (a) 3. SEC USE ONLY 4. CITIZENSHIP OR PLACE OF ORGANIZATION Australianpital Territory] [USIP O C 13G Page 1 of 15 Joint Filingreement March STYLE="font-family:Times New Roman" SIZE="2"> Thisreement may be executed in multipleunterparts, each of which shallnstitute an original, one and theme instrument.mmonwealth Bank of Australia Johnmien Hattonmpany Secretarylonialmpany Limited Johnmien Hatton] [USIP O C 13G Page 1 of 15 Item7 Information STYLE="font-family:Times New Roman" SIZE="2"> The securities being reported on by the reporting persons herein parentmpanies are owned, or may be deemed to be beneficially owned follows:mpany Type ofmpany. First State Investments (Hong Kong) Limited IA (HK registered)]

SKBI [SKYSTAR BIO-PHARMACEUTICAL] DEF 14A: (Original Filing)

[Skystar Bio-Pharmaceuticalmpany Notice of Annual Meeting and Proxy Statement Annual Meeting to be held on April 27, 2012, at 4/F Building B Chuangye Square, No. 48 Keji Road, Gaoxin District, Xian, Shaanxi Province, P.R. China, at 7:45pm, local timeystar Bio-Pharmaceuticalmpany 4/F Building B Chuangye Square, No. 48 Keji Road,]

By | 2016-02-05T03:18:48+00:00 April 3rd, 2012|Categories: Chinese Stocks, SEC Original, SKBI|Tags: , , , , , |0 Comments
Skip to toolbar